Check-Cap Ltd. (NASDAQ:CHEK – Get Free Report) crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $0.97 and traded as high as $1.79. Check-Cap shares last traded at $1.19, with a volume of 1,220,987 shares trading hands.
Analyst Ratings Changes
Separately, StockNews.com started coverage on shares of Check-Cap in a research report on Friday. They issued a “sell” rating on the stock.
View Our Latest Research Report on Check-Cap
Check-Cap Trading Down 7.6 %
Check-Cap Company Profile
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation.
Read More
- Five stocks we like better than Check-Cap
- How to trade using analyst ratings
- Buffett Takes the Bait; Berkshire Buys More Oxy in December
- What Are Dividend Achievers? An Introduction
- Top 3 ETFs to Hedge Against Inflation in 2025
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- These 3 Chip Stock Kings Are Still Buys for 2025
Receive News & Ratings for Check-Cap Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Check-Cap and related companies with MarketBeat.com's FREE daily email newsletter.